You are here

Article Text

Article menu

Download PDFPDF

Correspondence
Clinical evidence guidelines in systemic lupus erythematosus: revaluation
Free
  1. Morton Scheinberg
  1. Department of Rheumatology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil
  1. Correspondence to Professor Morton Scheinberg, Department of Rheumatology, Hospital Iisraelita Albert Einstein, Sao Paulo 05652000, Brazil; morton{at}osite.com.br

https://doi.org/10.1136/annrheumdis-2018-214357

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The paper on the First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus (SLE) points to some conclusions that need to be further clarified since the bulk of evidence points to a different direction.1 Belimumab safety and efficacy has been well documented since its approval during the last 5 years, and in particular the skin and joint domains appear to have …

    View Full Text

    Linked Articles